Correction to 'Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicity'

NAR Cancer. 2021 Dec 7;3(4):zcab047. doi: 10.1093/narcan/zcab047. eCollection 2021 Dec.

¹ Cybrexa Therapeutics, New Haven, CT 06511, USA.
² Department of Pathology, Yale University School of Medicine, New Haven, CT 06520, USA.
³ Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06520, USA.
⁴ Physics Department, University of Rhode Island, Kingston, RI 02881, USA.
⁵ Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06511, USA.

Abstract